|
Name |
8-Propionyl-neosolaniol
|
| Molecular Formula | C22H30O9 | |
| IUPAC Name* |
[(2R,4S,10R,11S)-11-acetyloxy-2-(acetyloxymethyl)-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-yl] propanoate
|
|
| SMILES |
CCC(=O)O[C@H]1C[C@]2(C(C=C1C)OC3[C@@H]([C@H](C2(C34CO4)C)OC(=O)C)O)COC(=O)C
|
|
| InChI |
InChI=1S/C22H30O9/c1-6-16(25)30-14-8-21(9-27-12(3)23)15(7-11(14)2)31-19-17(26)18(29-13(4)24)20(21,5)22(19)10-28-22/h7,14-15,17-19,26H,6,8-10H2,1-5H3/t14-,15?,17+,18+,19?,20?,21+,22?/m0/s1
|
|
| InChIKey |
ZSGWJLBSFZRJAT-ZCJGQMPNSA-N
|
|
| Synonyms |
8-propionylneosolaniol; 8-Propionyl-neosolaniol; P-NEO
|
|
| CAS | NA | |
| PubChem CID | 102515220 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 438.5 | ALogp: | 0.1 |
| HBD: | 1 | HBA: | 9 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 121.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 31 | QED Weighted: | 0.294 |
| Caco-2 Permeability: | -5.261 | MDCK Permeability: | 0.00007210 |
| Pgp-inhibitor: | 0.961 | Pgp-substrate: | 0.993 |
| Human Intestinal Absorption (HIA): | 0.357 | 20% Bioavailability (F20%): | 0.374 |
| 30% Bioavailability (F30%): | 0.957 |
| Blood-Brain-Barrier Penetration (BBB): | 0.305 | Plasma Protein Binding (PPB): | 32.40% |
| Volume Distribution (VD): | 1.044 | Fu: | 44.77% |
| CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.086 |
| CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.648 |
| CYP2C9-inhibitor: | 0.012 | CYP2C9-substrate: | 0.044 |
| CYP2D6-inhibitor: | 0.021 | CYP2D6-substrate: | 0.118 |
| CYP3A4-inhibitor: | 0.345 | CYP3A4-substrate: | 0.401 |
| Clearance (CL): | 3.347 | Half-life (T1/2): | 0.233 |
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.624 |
| Drug-inuced Liver Injury (DILI): | 0.835 | AMES Toxicity: | 0.427 |
| Rat Oral Acute Toxicity: | 0.937 | Maximum Recommended Daily Dose: | 0.175 |
| Skin Sensitization: | 0.066 | Carcinogencity: | 0.125 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
| Respiratory Toxicity: | 0.102 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002259 | ![]() |
0.874 | D0G7KJ | ![]() |
0.285 | ||
| ENC003580 | ![]() |
0.870 | D0L2UN | ![]() |
0.279 | ||
| ENC001179 | ![]() |
0.859 | D0OL7F | ![]() |
0.275 | ||
| ENC003104 | ![]() |
0.826 | D09SIK | ![]() |
0.275 | ||
| ENC003086 | ![]() |
0.742 | D0H2MO | ![]() |
0.271 | ||
| ENC005517 | ![]() |
0.729 | D09IEE | ![]() |
0.270 | ||
| ENC005516 | ![]() |
0.707 | D01ZOG | ![]() |
0.268 | ||
| ENC005586 | ![]() |
0.598 | D08BDT | ![]() |
0.266 | ||
| ENC005587 | ![]() |
0.425 | D0X2LV | ![]() |
0.262 | ||
| ENC005782 | ![]() |
0.336 | D09WYX | ![]() |
0.257 | ||